Details for 2010786869
Up to date per 21.04.2026
Actions
Details for 2010786869
Granted/Registered
European Patent
18.04.2012 A
18.07.2018 B1
10.06.2009
US
185800 P
22.09.2009
US
244834 P
A61K 9/127 20060101AFI20180118BHEP
Owner
Arbutus Biopharma Corporation100- 8900 Glenlyon Parkway Burnaby, BC V5J 5J8CA
Representative
Representative
Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT
Inventor
AKINC, AkinC/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142US
DORKIN, Joseph, R.C/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142US
QIN, XiaojunC/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142US
CANTLEY, WilliamC/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142GB
MANOHARAN, MuthiahC/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142US
RAJEEV, Kallanthottathil, G.C/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142US
NARAYANANNAIR, Jayaprakash, K.C/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142US
JAYARAMAN, MuthusamyC/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142US
CHEN, JianxinC/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142US
ANSELL, StevenC/o Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA 02142US
Information about Fees